Skip to main content

Table 1 Characterization of patients with A-T

From: Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?

Variable   N (%)
Age (n = 18) 5–15 years 12 (66.6%)
16–25 years 6 (33.3%)
Nutritional status (n = 18) Malnutrition 6 (33.3%)
Normal body mass index 11 (61.1%)
Overweight 1 (5.5%)
Fat mass (n = 18) Low 2 (11.1%)
Adequate 9 (50.0%)
High 7 (38.9%)
Mid-upper arm muscle circumference (n = 18) Low 10 (55.5%)
Adequate 8 (44.4%)
Lipid profile (n = 18) High total cholesterol 10 (55.5%)
High LDL-c 10 (55.5%)
High triglyceride 8 (44.4%)
Low HDL-c 10 (55.5%)
High NHDL-c 11 (61.1%)
Diabetes mellitus (n = 18) >200 mg/dL 1 (5.5%)
Oral Glucose Tolerance Test (n = 11) Normal 5 (45.4%)
Glucose intolerance 1 (9.1%)
Insulin resistance 4 (36.4%)
Glucose intolerance and Insulin resistance 1 (9.1%)
ALT (n = 17) > 40 U/L 7 (41.2%)
AST/ALT (n = 17) > 1 10 (58.8%)
Hepatic steatosis (n = 17) No 6 (35.3%)
Mild 7 (41.2%)
Moderate 4 (23.5%)
Liver involvement (n = 17)   7 (41.2%)
  1. N (%)
  2. Legend: LDL-c low density lipoprotein cholesterol, HDL-c high density lipoprotein cholesterol, NHDL-c Non-HDL-c, ALT alanine aminotransferase, and AST/ALT aspartate aminotransferase/alanine aminotransferase